NCT05825300 is a NA clinical trial of Email message in Behavior, Health, sponsored by Geisinger Clinic.

Who is sponsoring NCT05825300?

NCT05825300 is sponsored by Geisinger Clinic.

What drugs are being tested in NCT05825300?

Interventions in NCT05825300: Email message, Social responsibility.

What condition does NCT05825300 study?

NCT05825300 studies Behavior, Health.

Is NCT05825300 still recruiting?

NCT05825300 is currently completed. Last updated 6 July 2023.

Last reviewed 2023-07-06 · How we verify

NCT05825300

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Encouraging Blood Donation in Patients With a Blood Type in Short Supply - Part 2

Completed NA Last updated 6 July 2023

What this trial tests

NA trial testing Email message in Behavior, Health in 40,486 participants. Completed in 3 July 2023.

Timeline

10 April 2023

Primary endpoint
3 July 2023

3 July 2023

Quick facts

Lead sponsor	Geisinger Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	40,486
Start date	10 April 2023
Primary completion	3 July 2023
Estimated completion	3 July 2023
Sites	1 location across United States

Drugs / interventions tested

Email message
Social responsibility

Conditions studied

Behavior, Health — all drugs for Behavior, Health →

Sponsor

Geisinger Clinic

Who can join

18 and older, any sex, with Behavior, Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to test whether emails that inform patients they have a blood type in need are more effective at encouraging patients to schedule and attend blood donation appointments, compared to email messages that do not mention the patient has a blood type in need.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Behavior, Health

Currently open trials in the same condition.

NCT06581484 — Improving Congenital Heart Disease Care · NA · recruiting
NCT06207084 — The Fit With Us Study · NA · recruiting
NCT06242704 — Train Your Brain 2.0 - Improving Memory and Decision Making Among Youth · NA · recruiting
NCT06599970 — Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility · recruiting
NCT06264258 — Game-based Pediatric Diabetes Education · NA · recruiting

Other Geisinger Clinic trials

Trials by the same sponsor.

NCT07197801 — Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso · NA · recruiting
NCT06936709 — Perioperative Colchicine for TKA · Phase 4 · not yet recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07028398 — CMSL Ambulatory Sensitive Condition Nudge Study 2 · NA · recruiting
NCT06696066 — PEERS Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05825300 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Geisinger Clinic
Last refreshed: 6 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05825300.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing